Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-001251
Request Summary: Adverse Drug Reactions (ADRs) for DEXILANT. Report numbers: 001021090, E2B_05841716, E2B_05864940, E2B_05850390. ADRs for ENTYVIO. Report numbers: 001017634, E2B_05863270. ADRs for ONDANSETRON. Report numbers: E2B_05864888, E2B_05825021, E2B_05815566. ADR for CUVITRU. Report number: 001014612.
Disposition: Disclosed in part
Number of pages: 231